Royal Society of Chemistry, Chemical Science, 5(11), p. 1216-1225, 2020
DOI: 10.1039/c9sc05586j
Full text: Download
Fragment-based drug discovery (FBDD) using 3-dimensional metallofragments is a new strategy for the identification of bioactive molecules.